Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01708590
Brief Title: Study of Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab (AMG 827) in Moderate to Severe Plaque Psoriasis Subjects (AMAGINE-1)

First Submitted : September 10, 2012
First Submitted that Met QC Criteria : October 15, 2012
First Posted : October 17, 2012 (Estimate)

Certification/Extension First Submitted : April 1, 2015
Certification/Extension First Submitted that Met QC Criteria : April 1, 2015
Certification/Extension First Posted : April 21, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : August 6, 2015
Last Update Posted : August 24, 2015 (Estimate)